KRISTINA BUROW

Profile

First Name

: KRISTINA

Middle Name

:

Last Name

: BUROW

Related Companies
Titles
Company Name
Related People
DIRECTOR
KILIMANJARO ENERGY, INC.
NATHANIEL DAVID, WILLIAM GRIDLEY, KLAUS LACKNER, ROBERT NELSEN, WILLIAM SCHLEICHER
DIRECTOR
LIMERICK BIOPHARMA INC
STEPHEN DOW, STEPHEN M. DOW, STEVE DOW, COREY GOODMAN, COREY S. GOODMAN, VING LEE, SCOTT MINICK, ASHA RAJAGOPAL, WENDYE ROBBINS, CHAD WAITE
DIRECTOR
RECEPTOS, INC.
MARCUS BOEHM, DOUG COLE, PAUL GRAYSON, SHEILA GUJRATHI, FAHEEM HASNAIN, CHRYSA MINEO, AMIR NASHAT, ROBERT NELSEN, ROBERT NELSON, ROBERT PEACH, WILLIAM RASTETTER, JAMES SCHMIDT, MICHAEL SHEFFERY, RAYMOND STEVENS, ED TORRES
DIRECTOR
TRELYS, INC.
DOUG CAMERON, THOMAS ERICKSON, JAY KOUBA
DIRECTOR
CENEXYS, INC.
PAUL BERNS, GRAHAM COOPER, JAMIE DANANBERG, NATHANIEL DAVID, NATHANIEL E. DAVID, TROY FOSTER, BOB GOELTZ, KEITH KLEIN, KEITH LEONARD, DAN MARQUESS, ROBERT NELSEN, CAMILLE SAMUELS, JOHN SMITHER, TAMARA TOMPKINS
DIRECTOR
LYCERA CORP
KRISTINA BURROW, DAVID CANTER, STEVE GILLIS, STEVEN GILLIS, GARY GLICK, GARY D. GLICK, MICHAEL HAYDEN, ROBERT KAMEN, NINA KJELLSON, JEFFREY LEIDEN, TIM MAYLEBEN, TIMOTHY MAYLEBEN, KATHLEEN M. METTERS, PAUL SEKHRI, MICHAEL STEINMETZ
EXECUTIVE OFFICER
ARCH VENTURE FUND VIII, L.P.
N/A ARCH VENTURE PARTNERS VIII, L.P., N/A ARCH VENTURE PARTNERS VIII, LLC, CLINTON W. BYBEE, KEITH L. CRANDELL, MARK MCDONNELL, ROBERT T. NELSEN, PAUL THURK
DIRECTOR
AGBIOME, LLC
BENJAMIN BELLDEGRUN, GERALD COWARD, DAVID CRUIKSHANK, MARIJN E. DEKKERS, THOMAS DIETZ, ANDREW GRAHAM, KRYSTA HARDEN, MICHAEL KOZIEL, ALISON F. LAWTON, WAYNE MERKELSON, AMIR NASHAT, PRZEMEK OBLOJ, PATRICK PACE, LARRY ROBBINS, JOHN RYALS, PAUL SCHULZE-LEFERT, SCOTT UKNES, ERIC WARD
DIRECTOR
METACRINE, INC.
ROBERT ADELMAN, RONALD EVANS, CAROL GALLAGHER, JACKIE HERNANDEZ, RICHARD HEYMAN, NEIL MCDONNELL, PATRICIA MILLICAN, TRISHA MILLICAN, AMIR NASHAT, KEN SONG, KENNETH SONG
DIRECTOR
SIENNA LABS, INC.
TIMOTHY K. ANDREWS, FREDERICK BEDDINGFIELD, FREDERICK C. BEDDINGFIELD III, DENNIS FENTON, TODD HARRIS, KEITH R. LEONARD JR., PAUL F. LIZZUL, BOB MORE, ROBERT MORE, ROBERT NELSEN, ROBERT NELSON, RIC PETERSON, TED SCHWARZ, DIANE STROEHMANN
DIRECTOR
SCHOLAR ROCK LLC
KATRINE BOSLEY, MICHAEL GILMAN, NAGESH MAHANTHAPPA, AMIR NASHAT, TIMOTHY SPRINGER
DIRECTOR
UNITY BIOTECHNOLOGY, INC.
PAUL BERNS, GRAHAM COOPER, JAMIE DANANBERG, NATHANIEL DAVID, NATHANIEL E. DAVID, TROY FOSTER, BOB GOELTZ, KEITH KLEIN, KEITH LEONARD, DAN MARQUESS, ROBERT NELSEN, CAMILLE SAMUELS, JOHN SMITHER, TAMARA TOMPKINS
EXECUTIVE OFFICER
ARCH VENTURE FUND IX, L.P.
N/A ARCH VENTURE PARTNERS IX, L.P., N/A ARCH VENTURE PARTNERS IX, LLC, CLINTON W. BYBEE, KEITH L. CRANDELL, MARK MCDONNELL, ROBERT T. NELSEN
DIRECTOR, EXECUTIVE OFFICER
BORAGEN, INC.
STEPHEN BENKOVIC, JOHN DOMBROSKY, PETER FARINA, RICH GIANNI, JULIE GRANT, TRACY JACKSON, RAJ KAUL, ROGER KEMBLE, JOEL MARCUS, PAUL SCHIMMEL, ESTHER VAN DEN BOOM
DIRECTOR
SIENNA BIOPHARMACEUTICALS, INC.
TIMOTHY K. ANDREWS, FREDERICK BEDDINGFIELD, FREDERICK C. BEDDINGFIELD III, DENNIS FENTON, TODD HARRIS, KEITH R. LEONARD JR., PAUL F. LIZZUL, BOB MORE, ROBERT MORE, ROBERT NELSEN, ROBERT NELSON, RIC PETERSON, TED SCHWARZ, DIANE STROEHMANN
DIRECTOR
SCHOLAR ROCK HOLDING CORP
ALAN BUCKLER, YUNG H. CHYUNG, ELAN Z. EZICKSON, JEFFREY FLIER, MICHAEL GILMAN, DAVID HALLAL, NAGESH MAHANTHAPPA, AMIR NASHAT, TIMOTHY SPRINGER
DIRECTOR
GOSSAMER BIO, INC.
RICHARD ARANDA, M.D., JOSHUA BILENKER, M.D., LAURA CARTER, PH.D., RUSSELL COX, THOMAS DANIEL, M.D., RENEE GALA, BRYAN GIRAUDO, SHEILA GUJRATHI, M.D., FAHEEM HASNAIN, JILL HOWE, RICHARD LIM, SANDRA MILLIGAN, M.D., J.D., ROBERT NELSEN, CARYN PETERSON, OTELLO STAMPACCHIA, PH.D., CHRISTIAN WAAGE, MICHAEL YI
DIRECTOR, EXECUTIVE OFFICER
VIR BIOTECHNOLOGY, INC.
ALEX BANGS, THOMAS DANIEL, KLAUS FRUEH, HOWARD HORN, MICHAEL KAMARCK, ROBERT MORE, ROBERT NELSEN, DIPCHAND NISHAR, PHILLIP PANG, JAY PARRISH, ROBERT PEREZ, SAIRA RAMASASTRY, VICKI SATO, GEORGE SCANGOS, ALPNA SETH, PHILIP SHARP, PHILLIP SHARP, HERBERT VIRGIN
DIRECTOR
BEAM THERAPEUTICS INC.
JOHN EVANS, MARK FISHMAN, CAROLE HO, STEPHEN KNIGHT, ROBERT NELSEN, ROBERT NELSON, MICHAEL YI, FENG ZHANG
DIRECTOR
VIVIDION THERAPEUTICS, INC.
PATRICIA L. ALLEN, FRED ASLAN, JOHN CLARKE, JOHN K. CLARKE, BENJAMIN CRAVATT, THOMAS E. DANIEL, TOM DANIEL, JEFFREY HATFIELD, RICHARD HEYMAN, JAKOB LOVEN, DIEGO K. MIRALLES, JOHN PARK, THOMAS WOIWODE
EXECUTIVE OFFICER
ARCH VENTURE FUND X, L.P.
N/A ARCH VENTURE PARTNERS X, L.P., N/A ARCH VENTURE PARTNERS X, LLC, KEITH L. CRANDELL, STEVEN GILLIS, MARK MCDONNELL, ROBERT T. NELSEN, PAUL THURK
EXECUTIVE OFFICER
ARCH VENTURE FUND X OVERAGE, L.P.
N/A ARCH VENTURE PARTNERS X OVERAGE, L.P., N/A ARCH VENTURE PARTNERS X, LLC, KEITH L. CRANDELL, STEVEN GILLIS, MARK MCDONNELL, ROBERT T. NELSEN, PAUL THURK
DIRECTOR
BOUNDLESS BIO, INC.
CHRISTINE BRENNAN, PH.D., HO SUNG CHO, PH.D., JASON CHRISTIANSEN, PH.D., BENJAMIN CRAVATT, PH.D., CHRIS HASSIG, PH.D., ZACHARY D. HORNBY, JENNIFER LEW, JONATHAN LIM, M.D., JONATHAN E. LIM, M.D., JAKOB LOVEN, PH.D., SCOTT MOOREFIELD, PH.D., CAROLYN NG, PH.D., FABIO PUCCI, PH.D.
EXECUTIVE OFFICER
ARCH VENTURE FUND XI, L.P.
N/A ARCH VENTURE PARTNERS XI, L.P., N/A ARCH VENTURE PARTNERS XI, LLC, KEITH L. CRANDELL, JASON DOREN, STEVEN GILLIS, MARK MCDONNELL, ROBERT T. NELSEN
DIRECTOR
TREELINE BIOSCIENCES, INC.
JOSHUA H. BILENKER, DAVID BONITA, STEVEN ELMS, JEFFREY ENGELMAN, AFTAB KHERANI, AVI NAIDER, ALI SATVAT, DAVID SCHENKEIN
EXECUTIVE OFFICER
ARCH VENTURE FUND XII, L.P.
N/A ARCH VENTURE PARTNERS XII, L.P., N/A ARCH VENTURE PARTNERS XII, LLC, PAUL BERNS, KEITH L. CRANDELL, JASON DOREN, STEVEN GILLIS, MARK MCDONNELL, ROBERT T. NELSEN
DIRECTOR
NEUMORA THERAPEUTICS, INC.
PAUL BERNS, MATTHEW FUST, ALAA HALAWA, MAYKIN HO, ROBERT NELSEN, JOSHUA PINTO, KARI STEFANSSON, TAMARA TOMPKINS, STACIE WENINGER
DIRECTOR
MIRADOR THERAPEUTICS, INC.
TIMOTHY K. ANDREWS, PAUL BERNS, DAVID BONITA, M.D., VIKA BROUGH, SCOTT GLENN, MARK C. MCKENNA, JOSEPH PAPA
DIRECTOR
AUTOBAHN THERAPEUTICS, INC.
TIMOTHY ANDERSON, JOHN BORKHOLDER, THOMAS CAHILL, BENJAMIN CRAVATT, PHILIP J DESOUZA, KEVIN FINNEY, SCOTT GIACOBELLO, UWE J SCHOENBECK, BONNIE VAN WILGENBURG
DIRECTOR
METSERA, INC.
CHRISTOPHER WHITTEN BERNARD, PAUL L. BERNS, BRIAN HUBBARD, STEVEN MARSO, CLIVE A. MEANWELL, JOSHUA PINTO, CHRISTOPHER J. VISIOLI
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-09-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-08-21 
2024-11-20
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2024-11-12 
2024-10-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-10-02 
2024-08-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-06-20 
2024-04-03
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2023-12-14 
2024-04-03
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2024-02-15 
2023-08-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-04-05 
2023-08-07
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-07-24 
2023-01-03
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-09-08 
2022-10-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-26 
2022-07-18
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2022-07-15 
2022-04-01
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2022-02-04 
2021-05-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-23 
2021-04-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-04-09 
2021-03-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-18 
2021-01-28
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2020-11-20 
2020-05-15
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2019-12-20 
2020-05-08
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-05-06 
2020-05-08
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-04-29 
2020-03-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-08-24 
2020-01-03
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2019-12-20 
2019-10-25
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2018-11-16 
2019-10-25
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2018-11-16 
2019-05-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-24 
2019-03-26
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-02-09 
2019-03-26
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-08 
2019-02-28
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2019-02-15 
2018-08-09
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-02-09 
2018-08-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-20 
2018-07-17
D
Link
AGRICULTURE 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-16 
2018-06-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-14 
2018-06-20
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-05 
2018-03-27
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-03-15 
2018-01-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-04 
2018-01-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-01-04 
2018-01-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-12-22 
2017-12-13
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2017-11-30 
2017-08-21
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-10-14 
2017-05-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-04-12 
2017-05-15
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-10-08 
2017-04-12
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-29 
2017-03-22
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-01 
2016-12-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-10-14 
2016-11-18
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2016-05-05 
2016-11-09
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-30 
2016-01-04
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-12-17 
2015-10-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-10-08 
2015-10-06
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-30 
2015-08-21
D
Link
AGRICULTURE 
 
DECLINE TO DISCLOSE 
Equity 
2015-08-07 
2015-06-22
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2015-06-12 
2014-08-27
D/A
Link
VENTURE CAPITAL FUND 
 
NOT APPLICABLE 
 
2014-05-08 
2014-04-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2014-03-21 
2013-07-15
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2013-07-03 
2013-03-08
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-02-22 
2012-02-17
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2012-02-03 
2011-07-26
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2010-11-03 
2011-03-10
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2010-11-03 
2010-12-20
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2010-11-03 
2010-08-06
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-07-26 
2010-08-06
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2010-07-26